ymjЯкутский медицинский журналYakut Medical Journal1813-19052312-1017ЯНЦ КМП10.25789/YMJ.2025.90.13ymj-775Research ArticleЗДОРОВЫЙ ОБРАЗ ЖИЗНИ. ПРОФИЛАКТИКАHEALTHY LIFESTYLE. PROPHYLAXISОтношение детских гастроэнтерологов, ревматологов и родителей к вакцинации на основе анонимного онлайн-опросаAttitudes of pediatric gastroenterologists, rheumatologists and parents to vaccination based on an anonymous online surveyhttps://orcid.org/0000-0001-9866-5892МакароваЕ. Ю.MakarovaE. Yu.

Макарова Елизавета Юрьевна – врачпедиатр, ассистент кафедры.

194100, Санкт-Петербург, ул. Литовская, д. 2

elizaveta.lap@gmail.comhttps://orcid.org/0000-0002-8608-7797ХаритоноваЕ. С.KharitonovaE. S.

Харитонова Екатерина Сергеевна – ассистент кафедры.

194100, Санкт-Петербург, ул. Литовская, д. 2

romanovaes@mail.ruhttps://orcid.org/0000-0002-7931-2263ГабрусскаяТ. В.GabrusskayaT. V.

Габрусская Татьяна Викторовна – к.м.н., врач педиатр-гастроэнтеролог.

194100, Санкт-Петербург, ул. Литовская, д. 2

tatyanaga-brusskaya@yandex.ruhttps://orcid.org/0000-0003-2487-0783ШиловаЕ. В.ShilovaE. V.

Шилова Елена Вадимовна – врач педиатр-гастроэнтеролог.

194100, Санкт-Петербург, ул. Литовская, д. 2

komarova_lena@mail.ruhttps://orcid.org/0000-0003-1262-4681УлановаН. Б.UlanovaN. B.

Уланова Наталья Борисовна – врач педиатр-гастроэнтеролог.

194100, Санкт-Петербург, ул. Литовская, д. 2

natulan@inbox.ruhttps://orcid.org/0000-0003-0282-0953ВолковаН. Л.VolkovaN. L.

Волкова Наталья Леонидовна – врач педиатр-гастроэнтеролог.

194100, Санкт-Петербург, ул. Литовская, д. 2

volkovanatalia.dr@yandex.ruhttps://orcid.org/0009-0008-3084-012XКулешоваА. Г.KuleshovaA. G.

Кулешова Анастасия Григорьевна – студент 6 курса.

194100, Санкт-Петербург, ул. Литовская, д. 2

kuleshova130302@gmail.comhttps://orcid.org/0000-0002-3537-7372РевноваМ. О.RevnovaM. O.

Ревнова Мария Олеговна – д.м.н., проф. педиатр-гастроэнтеролог.

194100, Санкт-Петербург, ул. Литовская, д. 2

revnoff@mail.ruhttps://orcid.org/0000-0002-0060-4168ИвановД. О.IvanovD. O.

Иванов Дмитрий Олегович – д.м.н., проф., ректор, гл. внештат. специалист неонатолог.

194100, Санкт-Петербург, ул. Литовская, д. 2

doivanov@yandex.ruhttps://orcid.org/0000-0002-1180-8086КостикМ. М.KostikM. M.

Костик Михаил Михайлович – д.м.н., проф., врач педиатрревматолог.

194100, Санкт-Петербург, ул. Литовская, д. 2

kost-mikhail@yandex.ruФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава РФРоссия202522062025026165Copyright © Макарова Е.Ю., Харитонова Е.С., Габрусская Т.В., Шилова Е.В., Уланова Н.Б., Волкова Н.Л., Кулешова А.Г., Ревнова М.О., Иванов Д.О., Костик М.М., 20252025Макарова Е.Ю., Харитонова Е.С., Габрусская Т.В., Шилова Е.В., Уланова Н.Б., Волкова Н.Л., Кулешова А.Г., Ревнова М.О., Иванов Д.О., Костик М.М.Makarova E.Y., Kharitonova E.S., Gabrusskaya T.V., Shilova E.V., Ulanova N.B., Volkova N.L., Kuleshova A.G., Revnova M.O., Ivanov D.O., Kostik M.M.This work is licensed under a Creative Commons Attribution 4.0 License.https://ymj.elpub.ru/jour/article/view/775

Проведена оценка различий в охвате вакцинацией между пациентами с воспалительными заболеваниями кишечника (ВЗК), ювенильным идиопатическим артритом (ЮИА) и здоровыми детьми; выявлены различия во взглядах родителей и врачей на вакцинацию, включая факторы, препятствующие и способствующие вакцинации. Оценивались охват вакцинацией, причины отказа, уровень доверия к прививкам, а также участие врачей в процессе иммунизации. Установленный недостаточный охват вакцинацией среди пациентов с ВЗК и ЮИА обусловлен как сомнением родителей, так и осторожностью врачей-специалистов. Основными барьерами остаются необоснованные медицинские отводы, опасения обострения заболевания и недостаточное взаимодействие между врачами первичного звена и узкими специалистами, а также врачами и родителями пациентов. Для повышения охвата вакцинацией необходимы разработка персонализированных стратегий иммунизации, междисциплинарное сотрудничество и образовательные программы для врачей и родителей.

Differences in vaccination coverage among patients with IBD, JIA, and healthy children, as well as to identify differences in vaccination attitudes between parents and physicians, including barriers and facilitators of immunization were assessed. Vaccination coverage, reasons for refusal, trust in vaccines, and physician involvement in immunization were assessed. Statistical analysis was performed using Pearson’s χ² test and the MannWhitney test. Insufficient vaccination coverage among patients with IBD and JIA is influenced by both parental concerns and the cautious approach of specialists. The main barriers include medical exemptions, concerns about disease exacerbation, and inadequate coordination between primary care physicians and specialists. Improving vaccination coverage requires the development of personalized immunization strategies, interdisciplinary collaboration, and educational programs for both physicians and parents. To increase vaccination coverage, personalized immunization strategies, interdisciplinary collaboration, and educational programs for doctors and parents are needed.

вакцинацияювенильный идиопатический артритвоспалительные заболевания кишечникаохват вакцинациейиммуновоспалительные заболеванияvaccinationjuvenile idiopathic arthritisinflammatory bowel diseasevaccination coverageimmune-inflammatory diseasesReferencesBenchimol E.I., Tse F., Carroll M.W., et al. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD) – Part 1: Live Vaccines. Journal of the Canadian Association of Gastroenterology, 2021; 4(4): e59– e71. https://doi.org/10.1093/jcag/gwab015Benchimol E.I., Tse F., Carroll M.W., et al. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD) – Part 1: Live Vaccines. Journal of the Canadian Association of Gastroenterology, 2021; 4(4): e59– e71. https://doi.org/10.1093/jcag/gwab015Doran M.F., Crowson C.S., Pond G.R., O'Fallon W.M., Gabriel S.E. Predictors of infection in rheumatoid arthritis. Arthritis and Rheumatism, 2002; 46(9): 2294–2300. https://doi.org/10.1002/art.10529Doran M.F., Crowson C.S., Pond G.R., O'Fallon W.M., Gabriel S.E. Predictors of infection in rheumatoid arthritis. Arthritis and Rheumatism, 2002; 46(9): 2294–2300. https://doi.org/10.1002/art.10529Fleurier A., Pelatan C., Willot S., et al. Vaccination coverage of children with inflammatory bowel disease after an awareness campaign on the risk of infection. Digestive and Liver Disease, 2015; 47(6): 460–464. https://doi.org/10.1016/j.dld.2015.02.009Fleurier A., Pelatan C., Willot S., et al. Vaccination coverage of children with inflammatory bowel disease after an awareness campaign on the risk of infection. Digestive and Liver Disease, 2015; 47(6): 460–464. https://doi.org/10.1016/j.dld.2015.02.009Jansen M.H.A., Rondaan C., Legger G.E., et al. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Annals of the Rheumatic Diseases, 2022. https://doi.org/10.1136/annrheumdis-2022-222574Jansen M.H.A., Rondaan C., Legger G.E., et al. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Annals of the Rheumatic Diseases, 2022. https://doi.org/10.1136/annrheumdis-2022-222574Jansen M.H.A., Rondaan C., Legger G.E., et al. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Annals of the Rheumatic Diseases, 2023; 82(1): 35–47. https://doi.org/10.1136/annrheumdis-2022-222574Jansen M.H.A., Rondaan C., Legger G.E., et al. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Annals of the Rheumatic Diseases, 2023; 82(1): 35–47. https://doi.org/10.1136/annrheumdis-2022-222574Kostik M.M., Lubimova N.A., Fridman I.V., Goleva O.V., Kharit S.M. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study. Pediatric Rheumatology Online Journal, 2021; 19(1): 108. https://doi.org/10.1186/s12969-021-00594-2Kostik M.M., Lubimova N.A., Fridman I.V., Goleva O.V., Kharit S.M. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study. Pediatric Rheumatology Online Journal, 2021; 19(1): 108. https://doi.org/10.1186/s12969-021-00594-2Kucharzik T., Ellul P., Greuter T., et al. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn's and Colitis, 2021; 15(6): 879–913. https://doi.org/10.1093/ecco-jcc/jjab052Kucharzik T., Ellul P., Greuter T., et al. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn's and Colitis, 2021; 15(6): 879–913. https://doi.org/10.1093/ecco-jcc/jjab052Lamb C.A., Kennedy N.A., Raine T., et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut, 2019; 68(Suppl 3): s1–s106. https://doi.org/10.1136/gutjnl-2019-318484Lamb C.A., Kennedy N.A., Raine T., et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut, 2019; 68(Suppl 3): s1–s106. https://doi.org/10.1136/gutjnl-2019-318484Lester R., Lu Y., Tung J. Survey of Immunization Practices in Patients With Inflammatory Bowel Disease Among Pediatric Gastroenterologists. Journal of Pediatric Gastroenterology and Nutrition, 2015; 61(1): 47–51. https://doi.org/10.1097/MPG.0000000000000730Lester R., Lu Y., Tung J. Survey of Immunization Practices in Patients With Inflammatory Bowel Disease Among Pediatric Gastroenterologists. Journal of Pediatric Gastroenterology and Nutrition, 2015; 61(1): 47–51. https://doi.org/10.1097/MPG.0000000000000730Lichtenstein G.R., Feagan B.G., Cohen R.D., et al. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT registry. American Journal of Gastroenterology, 2012; 107(9): 1409–1422. https://doi.org/10.1038/ajg.2012.218Lichtenstein G.R., Feagan B.G., Cohen R.D., et al. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT registry. American Journal of Gastroenterology, 2012; 107(9): 1409–1422. https://doi.org/10.1038/ajg.2012.218Martinelli M., Giugliano F.P., Strisciuglio C., et al. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN. Inflammatory Bowel Diseases, 2020; 26(9): 1407–1414.Martinelli M., Giugliano F.P., Strisciuglio C., et al. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN. Inflammatory Bowel Diseases, 2020; 26(9): 1407–1414.Morin M.P., Quach C., Fortin E., Chédeville G. Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre. Rheumatology (Oxford, England), 2012; 51(11): 2046–2050. https://doi.org/10.1093/rheumatology/kes175Morin M.P., Quach C., Fortin E., Chédeville G. Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre. Rheumatology (Oxford, England), 2012; 51(11): 2046–2050. https://doi.org/10.1093/rheumatology/kes175Osterman M.T., Sandborn W.J., Colombel J.F., et al. Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab. American Journal of Gastroenterology, 2016; 111(12): 1806–1815. https://doi.org/10.1038/ajg.2016.433Osterman M.T., Sandborn W.J., Colombel J.F., et al. Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab. American Journal of Gastroenterology, 2016; 111(12): 1806–1815. https://doi.org/10.1038/ajg.2016.433Rahier J.F., Magro F., Abreu C., et al. Second European evidence-based consensus on the prevention, diagnosis, and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn's and Colitis, 2014; 8(6): 443–468. https://doi.org/10.1016/j.crohns.2013.12.013Rahier J.F., Magro F., Abreu C., et al. Second European evidence-based consensus on the prevention, diagnosis, and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn's and Colitis, 2014; 8(6): 443–468. https://doi.org/10.1016/j.crohns.2013.12.013Toruner M., Loftus E.V. Jr., Harmsen W.S., et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology, 2008; 134(4): 929–936. https://doi.org/10.1053/j.gastro.2008.01.012Toruner M., Loftus E.V. Jr., Harmsen W.S., et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology, 2008; 134(4): 929–936. https://doi.org/10.1053/j.gastro.2008.01.012Zullow S., Farraye F.A. Updates on vaccinating the inflammatory bowel disease patient. Expert Review of Gastroenterology & Hepatology, 2019; 13(3): 229–239. https://doi.org/10.1080/17474124.2019.1565993Zullow S., Farraye F.A. Updates on vaccinating the inflammatory bowel disease patient. Expert Review of Gastroenterology & Hepatology, 2019; 13(3): 229–239. https://doi.org/10.1080/17474124.2019.1565993

The authors declare that there are no conflicts of interest present.